| Metric | შპს ბელმარტი | შპს CD company | შპს ჯორჯიან ფარმაცევტიკალსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾8.1m₾3.5m | ₾8.2m₾7.6m | ₾7.9m₾6.6m |
| Revenue growth | 131.6% | 7.6% | 18.9% |
| Profitability | |||
| EBITDA | ₾1.4m₾562k | ₾391k₾1.1m | ₾2.8m₾1.9m |
| EBITDA margin | 17.1%16.0% | 4.8%14.3% | 35.4%29.4% |
| Net profit | ₾1.4m₾526k | ₾284k₾1.1m | ₾2.6m₾1.4m |
| Net margin | 17.7%15.0% | 3.5%15.0% | 33.6%20.8% |
| Balance sheet | |||
| Total assets | ₾2.3m₾1.1m | ₾4.2m₾4.7m | ₾7.9m₾5.6m |
| Total equity | ₾1.9m₾576k | ₾2.8m₾3.3m | ₾7.9m₾5.1m |
| ROE | 74.5%91.3% | 10.3%34.3% | 33.5%27.0% |